Oxford Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-6,281
| Closed | -$409K | – | 797 |
|
|
2019
Q4 | $409K | Buy |
+6,281
| New | +$409K | 0.01% | 1320 |
|
|
2018
Q3 | – | Sell |
-11,671
| Closed | -$1.51M | – | 1826 |
|
|
2018
Q2 | $1.51M | Sell |
11,671
-3,522
| -23% | -$457K | 0.03% | 825 |
|
|
2018
Q1 | $1.57M | Sell |
15,193
-9,137
| -38% | -$941K | 0.03% | 704 |
|
|
2017
Q4 | $2.09M | Buy |
24,330
+6,293
| +35% | +$540K | 0.05% | 549 |
|
|
2017
Q3 | $1.52M | Sell |
18,037
-4,589
| -20% | -$386K | 0.03% | 751 |
|
|
2017
Q2 | $1.71M | Buy |
+22,626
| New | +$1.71M | 0.03% | 674 |
|
|
2016
Q2 | – | Sell |
-58,235
| Closed | -$3.89M | – | 840 |
|
|
2016
Q1 | $3.89M | Buy |
58,235
+13,391
| +30% | +$894K | 0.11% | 228 |
|
|
2015
Q4 | $3M | Buy |
+44,844
| New | +$3M | 0.07% | 308 |
|
|
2015
Q2 | – | Sell |
-71,418
| Closed | -$3.44M | – | 698 |
|
|
2015
Q1 | $3.44M | Sell |
71,418
-292,453
| -80% | -$14.1M | 0.09% | 262 |
|
|
2014
Q4 | $12.1M | Buy |
363,871
+4,509
| +1% | +$150K | 0.27% | 60 |
|
|
2014
Q3 | $10.5M | Buy |
359,362
+129,760
| +57% | +$3.79M | 0.24% | 85 |
|
|
2014
Q2 | $8.85M | Buy |
229,602
+1,976
| +0.9% | +$76.2K | 0.29% | 85 |
|
|
2014
Q1 | $9.55M | Buy |
227,626
+34,827
| +18% | +$1.46M | 0.28% | 109 |
|
|
2013
Q4 | $6.33M | Buy |
+192,799
| New | +$6.33M | 0.16% | 190 |
|
|
2013
Q3 | – | Sell |
-143,308
| Closed | -$3.35M | – | 852 |
|
|
2013
Q2 | $3.35M | Buy |
+143,308
| New | +$3.35M | 0.09% | 355 |
|